UNSPSC 51152019: Butamisole hydrochloride

This classification denotes an antihelminthic agent with the molecular formula C15H19N3OS.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QGM18599H5, chemically known as propanamide, 2-methyl-n-(3-(2,3,5,6-tetrahydroimidazo(2,1-b)thizol-6-yl)phenyl)-, monohydrochloride, (-)- but generally known as butamisole hydrochloride, which bears US NIH Compound Identifier 166571. Most nations schedule butamisole hydrochloride under HS 29349990 and SITC 51579.

As of Q4 2014, BUTAMISOLE HYDROCHLORIDE remains the US FDA Preferred Term for this commodity. Butamisole hydrochloride bears US NLM identifiers UMLS ID C0700565 and NCI Concept Code C79919. SMILES: CC(C)C(=O)NC1=CC=CC(=C1)C2CN3CCSC3=N2.CL.

UNSPSC 51152019 Butamisole hydrochloride is a Commodity code that in practice captures pharmaceutical and veterinary chemical procurement by state and local health agencies, though recent sourcing activity under this code shows a substantial mismatch with its nominal scope. Seminole County, Florida posted an IFB for naloxone and drug deactivation systems—opioid-reversal medication and harm-reduction equipment—which falls outside the butamisole hydrochloride product line entirely. The code's actual procurement landscape remains unclear from available recent activity, as the single posted opportunity does not reflect the code's stated commodity.

Seminole County's IFB 60459723LAS, due July 26, 2023, sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract carried a two-year initial term with one-year renewal option, fixed-fee pricing, E-Verify compliance, workers' compensation and liability insurance requirements, and potential FEMA funding with associated federal environmental compliance obligations. No geographic concentration or pattern of repeat buyers emerges from the available record. State and local procurement professionals should treat this code with caution—the single recent opportunity tagged to it does not align with the butamisole hydrochloride product specification, suggesting either miscoding at the source or low activity under the code's intended scope.